Security
CM Life Sciences Inc. Class A Common Stock · CMLF
CMLFNASDAQCommon stockHistorical · closed Jul 22, 2021CIK 1818331Updated Nov 18, 2026
CMLF price & chart
This listing closed Jul 22, 2021. Live provider charts are shown only for current listings.
Current security: WGS
About the company
GeneDx’s (Nasdaq: WGS) mission is to empower everyone to live their healthiest life through genomics. GeneDx combines unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity ™ - the world’s largest rare disease genomic dataset. This unparalleled foundation powers GeneDx’s ExomeDx ™ and GenomeDx ® tests - ranked #1 by expert geneticists and granted FDA Breakthrough Device designation - enabling clinicians to deliver precise, fast, and actionable diagnoses. GeneDx Infinity also fuels discovery for biopharma, with the most powerful AI-driven genomic intelligence. A genomics pioneer over the last 25 years, diagnosing more than 4,800 genetic diseases and publishing more than 1,100 research publications, GeneDx is building the network that will drive the future of genomic precision medicine. For more information, visit genedx.com and connect with us on LinkedIn, Facebook, and Instagram.
In the news
No coverage from other publishers is available.
Recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
SCHEDULE 13G/A - filed by ARK Investment Management LLC regarding GeneDx Holdings Corp.
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
SCHEDULE 13G - filed by WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC regarding GeneDx Holdings Corp.
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 493,902,000Source | 408,840,000Source | 481,486,000Source | 463,863,000Source | 389,100,000Source | 506,301,000Source | 446,430,000Source | 394,528,000Source | 523,710,000Source | 419,380,000Source | 418,756,000Source | 490,942,000Source |
| Property, Plant and Equipment, NetUSD | — | — | 54,316,000Source | — | — | 50,125,000Source | — | — | 45,693,000Source | 32,893,000Source | 32,479,000Source | 51,527,000Source |
| GoodwillUSD | 12,798,000Source | — | 1,641,000Source | 12,926,000Source | — | 1,641,000Source | — | — | 13,520,000Source | — | — | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 172,585,000Source | 162,106,000Source | 141,350,000Source | 176,689,000Source | 165,613,000Source | 144,969,000Source | 155,094,000Source | 169,119,000Source | 168,481,000Source | 158,600,000Source | 172,625,000Source | 186,650,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 95,968,000Source | 57,894,000Source | 60,317,000Source | 74,120,000Source | 56,076,000Source | 93,924,000Source | 99,704,000Source | 83,673,000Source | 104,997,000Source | 85,212,000Source | 99,681,000Source | 123,933,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 60,938,000Source | — | 83,610,000Source | 48,028,000Source | — | 76,929,000Source | 45,983,000Source | — | 74,370,000Source | — | — | 42,634,000Source |
| Inventory, NetUSD | 10,569,000Source | 10,770,000Source | 17,820,000Source | 11,932,000Source | 10,322,000Source | 12,241,000Source | 12,662,000Source | 11,615,000Source | 13,951,000Source | 10,650,000Source | 8,777,000Source | 13,665,000Source |
| Assets, CurrentUSD | 237,583,000Source | 186,010,000Source | 246,360,000Source | 204,837,000Source | 162,167,000Source | 270,629,000Source | 225,816,000Source | 163,424,000Source | 268,288,000Source | 197,968,000Source | 182,339,000Source | 212,622,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 10,997,000Source | 20,300,000Source | 12,382,000Source | 10,319,000Source | 18,792,000Source | 10,774,000Source | 8,011,000Source | 9,974,000Source | 8,685,000Source | 8,504,000Source | 10,598,000Source | — |
| Operating Lease, Right-of-Use AssetUSD | 24,200,000Source | 24,936,000Source | 33,535,000Source | 24,978,000Source | 25,624,000Source | 34,653,000Source | 24,883,000Source | 26,304,000Source | 23,412,000Source | 25,613,000Source | 26,900,000Source | 32,758,000Source |
| Other Assets, NoncurrentUSD | 4,314,000Source | 4,336,000Source | 4,284,000Source | 4,313,000Source | 4,357,000Source | 4,284,000Source | 4,254,000Source | 4,380,000Source | 4,316,000Source | 4,306,000Source | 4,413,000Source | 6,485,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 201,644,000Source | 204,339,000Source | 237,265,000Source | 186,730,000Source | 195,057,000Source | 252,177,000Source | 189,025,000Source | 187,311,000Source | 215,528,000Source | 174,133,000Source | 190,739,000Source | 237,237,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 2,000Source | 2,000Source | 3,000Source | 2,000Source | 2,000Source | 3,000Source | 2,000Source | 2,000Source | 3,000Source | 2,000Source | 2,000Source | 38,000Source |
| Additional Paid in CapitalUSD | 1,647,083,000Source | 1,561,493,000Source | 1,698,427,000Source | 1,624,513,000Source | 1,543,182,000Source | 1,690,249,000Source | 1,615,501,000Source | 1,527,351,000Source | 1,680,738,000Source | 1,596,889,000Source | 1,527,778,000Source | 1,378,088,000Source |
| Retained Earnings (Accumulated Deficit)USD | -1,355,829,000Source | -1,357,912,000Source | -1,454,551,000Source | -1,348,194,000Source | -1,349,600,000Source | -1,436,811,000Source | -1,359,003,000Source | -1,320,427,000Source | -1,373,495,000Source | -1,352,474,000Source | -1,300,188,000Source | -1,124,421,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 1,002,000Source | 918,000Source | 342,000Source | 812,000Source | 459,000Source | 683,000Source | 905,000Source | 291,000Source | 936,000Source | 830,000Source | 425,000Source | — |
| Stockholders' Equity Attributable to ParentUSD | 292,258,000Source | 204,501,000Source | 244,221,000Source | 277,133,000Source | 194,043,000Source | 254,124,000Source | 257,405,000Source | 207,217,000Source | 308,182,000Source | 245,247,000Source | 228,017,000Source | 253,705,000Source |
| Liabilities and EquityUSD | 493,902,000Source | 408,840,000Source | 481,486,000Source | 463,863,000Source | 389,100,000Source | 506,301,000Source | 446,430,000Source | 394,528,000Source | 523,710,000Source | 419,380,000Source | 418,756,000Source | 490,942,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 87,621,000Source | 77,342,000Source | 74,628,000Source | 71,406,000Source | 68,270,000Source | 87,639,000Source | 69,541,000Source | 50,734,000Source | 108,908,000Source | 54,817,000Source | 58,818,000Source | 144,297,000Source |
| Operating Lease, Liability, CurrentUSD | — | — | — | — | — | — | — | — | 3,881,000Source | 2,608,000Source | 2,331,000Source | 2,409,000Source |
| Accounts Payable, CurrentUSD | 2,630,000Source | 9,022,000Source | 5,147,000Source | 3,522,000Source | 8,134,000Source | 11,168,000Source | 15,856,000Source | 9,477,000Source | 2,461,000Source | 7,954,000Source | 10,238,000Source | 46,017,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | — | — | — | — | — | — | — | 38,778,000Source | 42,698,000Source | 44,428,000Source | 44,468,000Source |
| Deferred Income Tax Liabilities, NetUSD | 1,033,000Source | 1,054,000Source | 873,000Source | 747,000Source | 1,167,000Source | 1,404,000Source | 1,153,000Source | 1,418,000Source | 757,000Source | 965,000Source | 1,560,000Source | 2,659,000Source |
| Other Liabilities, NoncurrentUSD | 4,258,000Source | 13,540,000Source | 71,000Source | 3,275,000Source | 12,660,000Source | 71,000Source | 6,619,000Source | 20,836,000Source | 1,641,000Source | 5,519,000Source | 14,735,000Source | 22,000,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 26,371,000Source | 11,075,000Source | 30,204,000Source | 28,116,000Source | 7,293,000Source | 24,657,000Source | 14,025,000Source | 11,292,000Source | 44,659,000Source | 11,504,000Source | 12,154,000Source | 38,861,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 757,000Source | 965,000Source | 1,560,000Source | 2,659,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 51,579,000Source | 52,034,000Source | 96,836,000Source | 51,683,000Source | 52,160,000Source | 96,732,000Source | 51,794,000Source | 52,293,000Source | 48,176,000Source | 51,913,000Source | 52,688,000Source | 6,250,000Source |
| Long-term Debt, Current MaturitiesUSD | 1,229,000Source | 1,205,000Source | 0Source | 1,223,000Source | 1,100,000Source | 0Source | 1,217,000Source | 798,000Source | 4,542,000Source | 1,211,000Source | 497,000Source | 4,750,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 51,579,000Source | 52,034,000Source | 96,836,000Source | 51,683,000Source | 52,160,000Source | 96,732,000Source | 51,794,000Source | 52,293,000Source | 48,176,000Source | 51,913,000Source | 52,688,000Source | 6,250,000Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 2,370,000Source | 2,422,000Source | 3,100,000Source | 2,300,000Source | 2,700,000Source | 2,200,000Source | 9,600,000Source | 7,900,000Source | 19,700,000Source | 59,309,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 8,996,000Source | 3,983,000Source | 32,162,000Source | 9,138,000Source | -326,000Source | 41,975,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 2,558,000Source | 8,557,000Source | 36,231,000Source | 5,421,000Source | -10,263,000Source | -5,527,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -1,689,000Source | 2,032,000Source | 3,436,000Source | 2,585,000Source | -975,000Source | -2,350,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -981,000Source | -584,000Source | -1,090,000Source | -49,124,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -32,408,000Source | 10,182,000Source | 33,279,000Source | -28,496,000Source | -180,147,000Source | -319,155,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | 0Source | 12,144,000Source | 127,004,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -17,255,000Source | -9,408,000Source | -61,517,000Source | -30,132,000Source | -43,726,000Source | -141,326,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 6,453,000Source | 6,129,000Source | 19,017,000Source | 5,491,000Source | 5,250,000Source | 7,156,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 38,590,000Source | 13,718,000Source | 48,025,000Source | 44,162,000Source | 186,238,000Source | 197,315,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -11,073,000Source | 14,492,000Source | 19,787,000Source | -14,466,000Source | -37,635,000Source | -263,166,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 96,958,000Source | 58,881,000Source | 61,310,000Source | 75,110,000Source | 94,916,000Source | 100,694,000Source | 105,989,000Source | 86,202,000Source | 100,668,000Source | 138,303,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 1,748,000Source | 1,600,000Source | 6,413,000Source | 6,677,000Source | 3,041,000Source | 1,932,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 661,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 10,586,000Source | 3,636,000Source | 6,342,000Source | 7,813,000Source | 8,996,000Source | 3,983,000Source | 32,162,000Source | 9,138,000Source | -326,000Source | 41,975,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 518,000Source |
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 0Source | 6,600,000Source | 15,400,000Source |
| DepreciationUSD | — | — | — | — | 3,095,000Source | 2,286,000Source | 2,705,000Source | 2,172,000Source | 9,605,000Source | 7,928,000Source | 19,709,000Source | 49,959,000Source |
| Depreciation, Amortization and Accretion, NetUSD | — | — | — | — | — | — | 6,809,000Source | 5,678,000Source | 25,224,000Source | 21,953,000Source | 33,734,000Source | — |
| Depreciation, NonproductionUSD | — | — | — | 600,000Source | — | — | — | — | — | 600,000Source | — | — |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | — | 0Source | 1,677,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | 1,700,000Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | — | -5,560,000Source | — | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | 0Source | 0Source | -6,565,000Source | 0Source | — | — | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 44,439,000Source | 26,919,000Source | — | 27,415,000Source | — | 32,134,000Source | 150,819,000Source | 101,110,000Source | 133,755,000Source | 203,329,000Source |
| GoodwillUSD | — | — | 12,798,000Source | — | 1,641,000Source | 12,926,000Source | 1,641,000Source | — | 13,520,000Source | — | — | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 11,879,000Source | — | — | — | — | 174,500,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 247,000Source | -47,000Source | -518,000Source | -246,000Source | 897,000Source | 447,000Source | -116,000Source | -343,000Source | -926,000Source | -49,052,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | — | — | 135,000Source | 180,000Source | 3,913,000Source | 1,125,000Source |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 2,541,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,635,000Source | -8,312,000Source | -17,740,000Source | 10,809,000Source | -63,316,000Source | -6,529,000Source | -21,021,000Source | -52,286,000Source | -175,767,000Source | -548,980,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,137,000Source | -579,000Source | -803,000Source | 1,603,000Source | -4,948,000Source | -1,531,000Source | -8,060,000Source | -29,416,000Source | 3,903,000Source | 69,620,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 6,044,000Source |
| Operating Lease, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 10,000,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -174,000Source | 1,144,000Source | 162,000Source | 239,000Source | -206,000Source | 209,000Source | -4,317,000Source | -13,014,000Source | 1,619,000Source | 57,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | -774,000Source | — | — | — | — | 0Source | -3,407,000Source | -7,223,000Source | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 476,000Source | 0Source | — | — | — | 197,659,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 48,549,000Source | 0Source |
| Proceeds from Issuance of Redeemable Preferred StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | — | — | — | — | — | — | 8,500,000Source | 13,930,000Source | 43,970,000Source | 41,060,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | 58,000Source | 735,000Source | 2,022,000Source | 394,000Source | 285,000Source | 2,948,000Source |
| Amortization of Intangible Assets | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| LitigationSettlementLoss | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Restructuring Costs | — | — | — | —Source | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 116,743,000Source | 76,874,000Source | 114,440,000Source | 102,692,000Source | 102,254,000Source | 87,115,000Source | 427,539,000Source | 305,450,000Source | 202,566,000Source | 234,694,000Source |
| Cost of RevenueUSD | — | — | 32,216,000Source | 29,045,000Source | 36,202,000Source | 31,790,000Source | 34,043,000Source | 28,639,000Source | 129,366,000Source | 111,053,000Source | 112,560,000Source | 261,444,000Source |
| Operating Income (Loss)USD | — | — | -3,251,000Source | -7,780,000Source | -17,455,000Source | 8,960,000Source | -57,471,000Source | -4,551,000Source | -13,077,000Source | -23,213,000Source | -180,596,000Source | -667,652,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -174,000Source | 1,144,000Source | 162,000Source | 239,000Source | -206,000Source | 209,000Source | -4,317,000Source | -13,014,000Source | 1,619,000Source | 57,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -7,388,000Source | -8,359,000Source | -18,258,000Source | 10,563,000Source | -62,419,000Source | -6,082,000Source | -21,137,000Source | -52,629,000Source | -176,693,000Source | -598,032,000Source |
| Income Tax Expense (Benefit)USD | — | — | 247,000Source | -47,000Source | -518,000Source | -246,000Source | 897,000Source | 447,000Source | -116,000Source | -343,000Source | -926,000Source | -49,052,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -7,635,000Source | -8,312,000Source | -17,740,000Source | 10,809,000Source | -63,316,000Source | -6,529,000Source | -21,021,000Source | -52,286,000Source | -175,767,000Source | -548,980,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.27Source | -0.31Source | -0.6Source | 0.38Source | -2.16Source | -0.23Source | -0.73Source | -1.94Source | -7.23Source | -1.63Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.27Source | -0.31Source | -0.6Source | 0.36Source | -2.16Source | -0.23Source | -0.73Source | -1.94Source | -7.23Source | -1.63Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 28,797,730Source | 27,095,986Source | 29,710,139Source | 28,579,704Source | 29,335,126Source | 28,147,948Source | 28,641,734Source | 26,891,213Source | 24,311,989Source | 337,819,680Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 28,797,730Source | 27,095,986Source | 29,710,139Source | 29,753,933Source | 29,335,126Source | 28,147,948Source | 28,641,734Source | 26,891,213Source | 24,311,989Source | 337,819,680Source |
| Additional Financial Items | ||||||||||||
| Capitalized Computer Software, AmortizationUSD | — | — | — | — | — | — | — | — | — | 0Source | 6,600,000Source | 15,400,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 865,000Source | 241,000Source | 164,000Source | 72,000Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | — | — | — | — | — | — | — | -5,560,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 44,439,000Source | 26,919,000Source | — | 27,415,000Source | — | 32,134,000Source | 150,819,000Source | 101,110,000Source | 133,755,000Source | 203,329,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | 11,879,000Source | — | — | — | — | 174,500,000Source |
| Gross ProfitUSD | — | — | 84,527,000Source | 47,829,000Source | 78,238,000Source | 70,902,000Source | 68,211,000Source | 58,476,000Source | 298,173,000Source | 194,397,000Source | 90,006,000Source | -26,750,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -22,315,000Source | -53,558,000Source | -177,316,000Source | -598,136,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 3,207,000Source |
| Interest Income (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | 1,114,000Source | — |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -562,000Source | -843,000Source | -1,185,000Source | -817,000Source | -717,000Source | -640,000Source | -2,539,000Source | -3,032,000Source | — | — |
| Investment Income, InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 2,541,000Source |
| Nonoperating Income (Expense)USD | — | — | -4,137,000Source | -579,000Source | -803,000Source | 1,603,000Source | -4,948,000Source | -1,531,000Source | -8,060,000Source | -29,416,000Source | 3,903,000Source | 69,620,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 6,044,000Source |
| Other Operating Income (Expense), NetUSD | — | — | — | -774,000Source | — | — | — | — | 0Source | -3,407,000Source | -7,223,000Source | — |
| Research and Development ExpenseUSD | — | — | 19,829,000Source | 11,665,000Source | 19,656,000Source | 15,079,000Source | 19,804,000Source | 12,577,000Source | 72,026,000Source | 45,722,000Source | 58,266,000Source | 86,203,000Source |
| Selling and Marketing ExpenseUSD | — | — | 23,510,000Source | 17,025,000Source | — | 19,448,000Source | — | 18,316,000Source | 88,405,000Source | 67,371,000Source | 60,956,000Source | 134,913,000Source |
| Selling, General and Administrative Expense | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| Amortization of Intangible Assets | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
| LitigationSettlementLoss | — | — | — | — | — | — | —Source | — | — | — | — | — |
| Restructuring Costs | — | — | — | —Source | — | — | — | — | — | — | — | — |
Filing attachments
tm2630089d1_ex99-1.htm · 8-K · 2026-11-18
Exhibit 99.1 GeneDx Announces Leadership Transition Everett Cunningham, veteran diagnostics and commercial leader, appointed Chief Executive Officer to lead next phase of growth Katherine Stueland announces her departure from the company after successful transformation of GeneDx GAITHERSBURG, Md - November 18, 2026 - GeneDx (Nasdaq: WGS), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced that its Board of Directors has appointed Ever…
Read attachment ↗p12167113_ex99-1.htm · SCHEDULE 13D/A · 2026-05-22
Exhibit 99.1 Schedule of Transactions in Shares Date of Transaction Reporting Person Title of Class Number of Shares Acquired (Disposed) Price Per Share (1) ─────────────────────────────────────────────────────────────────────────────────────────────────────…
Read attachment ↗